SCHEMBL4856298

SCHEMBL4856298

Oc1ccc(-n2c3ccc(N(c4ccccc4)c4ccccc4)cc3c3cc(N(c4ccccc4)c4ccccc4)ccc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.43
▸ GFER P55789 1/20 0.43
▸ HTT P42858 5/20 0.43
▸ HPGD P15428 4/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ LMNA P02545 2/20 0.43
▸ KMT2A Q03164 4/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ MAPT P10636 6/20 0.41
▸ KDM4E B2RXH2 5/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ PKM P14618 2/20 0.41
▸ ALOX15 P16050 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13059870 0.97 GAA (0.47) GAAGFERHTTHPGDSMN1; SMN2
SCHEMBL9913013 0.92 L3MBTL1 (0.45) GAAGFERHTTHPGDSMN1; SMN2
SCHEMBL9912865 0.92 L3MBTL1 (0.45) GAAGFERHTTHPGDSMN1; SMN2
SCHEMBL19034711 0.91 KDM4E (0.53) GAAGFERHTTHPGDSMN1; SMN2
SCHEMBL12856945 0.89 KDM4E (0.50) GAAGFERHTTHPGDSMN1; SMN2
SCHEMBL13301590 0.89 KDM4E (0.50) GAAGFERHTTHPGDSMN1; SMN2
SCHEMBL1981658 0.89 KDM4E (0.50) GAAGFERHTTHPGDSMN1; SMN2
SCHEMBL19429316 0.89 KDM4E (0.50) GAAGFERHTTHPGDSMN1; SMN2
SCHEMBL1144158 0.89 KDM4E (0.50) GAAGFERHTTHPGDSMN1; SMN2
SCHEMBL29450664 0.89 KDM4E (0.50) GAAGFERHTTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7348116-B2 Aromatic heterocyclic-based charge transport materials having two amino groups SAMSUNG ELECTRONICS, LTD (KR) 2008-03-25 — — US disclosed
US-7348116-B2 Aromatic heterocyclic-based charge transport materials having two amino groups SAMSUNG ELECTRONICS, LTD (KR) 2008-03-25 — — US disclosed
US-7348116-B2 Aromatic heterocyclic-based charge transport materials having two amino groups SAMSUNG ELECTRONICS, LTD (KR) 2008-03-25 — — US disclosed
US-20060051690-A1 Aromatic heterocyclic-based charge transport materials having two amino groups S-PRINTING SOLUTION CO., LTD. (KR) 2006-03-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060051690-A1 Aromatic heterocyclic-based charge transport materials having two amino groups SLC43A1, SLC6A19, SLC1A2 GAA 3464/4885GFER 1010/4885HTT 870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback